{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T03:55:56Z","timestamp":1764129356391,"version":"3.46.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372683"],"award-info":[{"award-number":["82372683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30059","2023JJ40067","2025JJ60588"],"award-info":[{"award-number":["2022JJ30059","2023JJ40067","2025JJ60588"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05900-9","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T03:52:46Z","timestamp":1764129166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone demethylase KDM9 activates the CCND1\/AKT pathway to promote the malignant progression of gliomas through interaction with BRD2"],"prefix":"10.1007","volume":"82","author":[{"given":"Jin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingzhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenghui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-8350","authenticated-orcid":false,"given":"Lifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"5900_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M et al (2024) Glioma. Nat Rev Dis Primers 10(1):33","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"5900_CR2","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70(4):299\u2013312","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5900_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.drudis.2019.03.008","volume":"24","author":"ED Zanders","year":"2019","unstructured":"Zanders ED, Svensson F, Bailey DS (2019) Therapy for glioblastoma: is it working? Drug Discov Today 24(5):1193\u20131201","journal-title":"Drug Discov Today"},{"issue":"1","key":"5900_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"5","key":"5900_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13(5):343\u2013357","journal-title":"Nat Rev Genet"},{"key":"5900_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183391","author":"S Gold","year":"2024","unstructured":"Gold S, Shilatifard A (2024) Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI183391","journal-title":"J Clin Invest"},{"issue":"4","key":"5900_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K et al (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324","journal-title":"Exp Mol Med"},{"issue":"8","key":"5900_CR8","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/thno.53347","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y et al (2021) KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma. Theranostics 11(8):3868\u20133881","journal-title":"Theranostics"},{"issue":"6","key":"5900_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41419-022-04983-7","volume":"13","author":"B Lu","year":"2022","unstructured":"Lu B et al (2022) Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3. Cell Death Dis 13(6):547","journal-title":"Cell Death Dis"},{"key":"5900_CR10","doi-asserted-by":"publisher","first-page":"15146","DOI":"10.1038\/ncomms15146","volume":"8","author":"J Li","year":"2017","unstructured":"Li J et al (2017) KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt\/beta-catenin signalling. Nat Commun 8:15146","journal-title":"Nat Commun"},{"issue":"1","key":"5900_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2017.07.041","volume":"171","author":"K Brejc","year":"2017","unstructured":"Brejc K et al (2017) Dynamic control of X chromosome conformation and repression by a histone H4K20 demethylase. Cell 171(1):85-102 e23","journal-title":"Cell"},{"issue":"6","key":"5900_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253897","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Comparative distributions of RSBN1 and methylated histone H4 lysine 20 in the mouse spermatogenesis. PLoS ONE 16(6):e0253897","journal-title":"PLoS ONE"},{"issue":"2","key":"5900_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10120-023-01464-4","volume":"27","author":"B Yue","year":"2024","unstructured":"Yue B et al (2024) Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism. Gastric Cancer 27(2):308\u2013323","journal-title":"Gastric Cancer"},{"issue":"1","key":"5900_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-017-0673-0","volume":"16","author":"B Abu-Jamous","year":"2017","unstructured":"Abu-Jamous B et al (2017) In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer. Mol Cancer 16(1):105","journal-title":"Mol Cancer"},{"issue":"10","key":"5900_CR15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41416-021-01545-0","volume":"125","author":"M Iden","year":"2021","unstructured":"Iden M et al (2021) Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes. Br J Cancer 125(10):1408\u20131419","journal-title":"Br J Cancer"},{"issue":"5","key":"5900_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1049\/syb2.12074","volume":"17","author":"X Zhang","year":"2023","unstructured":"Zhang X (2023) Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas. IET Syst Biol 17(5):259\u2013270","journal-title":"IET Syst Biol"},{"issue":"16","key":"5900_CR17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41388-023-02644-3","volume":"42","author":"P Zhou","year":"2023","unstructured":"Zhou P et al (2023) E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression. Oncogene 42(16):1308\u20131320","journal-title":"Oncogene"},{"issue":"1","key":"5900_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01763-x","volume":"9","author":"Y Yan","year":"2024","unstructured":"Yan Y et al (2024) Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis. Signal Transduct Target Ther 9(1):58","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"5900_CR19","doi-asserted-by":"publisher","first-page":"38811","DOI":"10.18632\/oncotarget.16402","volume":"8","author":"W Xia","year":"2017","unstructured":"Xia W et al (2017) Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-beta\/Smad-regulated liver cancer stem cell-like cells. Oncotarget 8(24):38811\u201338824","journal-title":"Oncotarget"},{"issue":"2","key":"5900_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113879","volume":"434","author":"Y Xu","year":"2024","unstructured":"Xu Y et al (2024) Silencing hsa_circ_0032449 inhibits the pancreatic differentiation of human embryonic stem cells via the hsa_miR-195-5p\/CCND1\/PI3K\/AKT signaling pathway. Exp Cell Res 434(2):113879","journal-title":"Exp Cell Res"},{"issue":"2","key":"5900_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/onc.2016.201","volume":"36","author":"Y Zhen","year":"2017","unstructured":"Zhen Y et al (2017) MiR-374a-CCND1-pPI3K\/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin. Oncogene 36(2):275\u2013285","journal-title":"Oncogene"},{"issue":"1","key":"5900_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13046-024-03140-6","volume":"43","author":"TY Liu","year":"2024","unstructured":"Liu TY et al (2024) FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A\/STAT3 transcription mechanism. J Exp Clin Cancer Res 43(1):213","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"5900_CR23","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.7150\/thno.58729","volume":"11","author":"MJ Wu","year":"2021","unstructured":"Wu MJ et al (2021) Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Theranostics 11(16):7779\u20137796","journal-title":"Theranostics"},{"issue":"4","key":"5900_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/neuonc\/noac231","volume":"25","author":"R Yang","year":"2023","unstructured":"Yang R (2023) Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro Oncol 25(4):635\u2013647","journal-title":"Neuro Oncol"},{"issue":"1","key":"5900_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1152\/physiolgenomics.00128.2020","volume":"53","author":"AZ Corvalan","year":"2021","unstructured":"Corvalan AZ, Coller HA (2021) Methylation of histone 4\u2019s lysine 20: a critical analysis of the state of the field. Physiol Genomics 53(1):22\u201332","journal-title":"Physiol Genomics"},{"issue":"1","key":"5900_CR26","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s42003-022-04241-8","volume":"5","author":"PO Est\u00e8ve","year":"2022","unstructured":"Est\u00e8ve PO et al (2022) Poly ADP-ribosylation of SET8 leads to aberrant H4K20 methylation in mammalian nuclear genome. Commun Biol 5(1):1292","journal-title":"Commun Biol"},{"issue":"18","key":"5900_CR27","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1074\/jbc.M707974200","volume":"283","author":"H Yang","year":"2008","unstructured":"Yang H (2008) Preferential dimethylation of histone H4 lysine 20 by Suv4-20. J Biol Chem 283(18):12085\u201312092","journal-title":"J Biol Chem"},{"issue":"9","key":"5900_CR28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1158\/1541-7786.MCR-17-0688","volume":"16","author":"KL Paquin","year":"2018","unstructured":"Paquin KL, Howlett NG (2018) Understanding the histone DNA repair code: H4K20me2 makes its mark. Mol Cancer Res 16(9):1335\u20131345","journal-title":"Mol Cancer Res"},{"issue":"1","key":"5900_CR29","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1038\/s41467-021-25051-2","volume":"12","author":"M Shoaib","year":"2021","unstructured":"Shoaib M et al (2021) Histone H4 lysine 20 mono-methylation directly facilitates chromatin openness and promotes transcription of housekeeping genes. Nat Commun 12(1):4800","journal-title":"Nat Commun"},{"issue":"16","key":"5900_CR30","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1074\/jbc.M111.223198","volume":"286","author":"Y Li","year":"2011","unstructured":"Li Y et al (2011) The histone modifications governing TFF1 transcription mediated by estrogen receptor. J Biol Chem 286(16):13925\u201313936","journal-title":"J Biol Chem"},{"issue":"8","key":"5900_CR31","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1073\/pnas.1009353108","volume":"108","author":"Z Li","year":"2011","unstructured":"Li Z et al (2011) Histone H4 lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci U S A 108(8):3116\u20133123","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"5900_CR32","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1158\/0008-5472.CAN-22-0848","volume":"82","author":"X Lu","year":"2022","unstructured":"Lu X et al (2022) Loss of LOXL2 promotes uterine hypertrophy and tumor progression by enhancing H3K36ac-dependent gene expression. Cancer Res 82(23):4400\u20134413","journal-title":"Cancer Res"},{"issue":"4","key":"5900_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","volume":"150","author":"W Yang","year":"2012","unstructured":"Yang W et al (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150(4):685\u2013696","journal-title":"Cell"},{"issue":"1","key":"5900_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41419-020-03354-4","volume":"12","author":"Z Cao","year":"2021","unstructured":"Cao Z et al (2021) KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer. Cell Death Dis 12(1):2","journal-title":"Cell Death Dis"},{"issue":"4","key":"5900_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41419-023-05763-7","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J et al (2023) Aberrant cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 14(4):244","journal-title":"Cell Death Dis"},{"issue":"7","key":"5900_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41389-020-00253-3","volume":"9","author":"M Caillot","year":"2020","unstructured":"Caillot M et al (2020) Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis 9(7):68","journal-title":"Oncogenesis"},{"issue":"1","key":"5900_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12967-021-02766-w","volume":"19","author":"J Yao","year":"2021","unstructured":"Yao J et al (2021) M2 macrophage-derived exosomal micrornas inhibit cell migration and invasion in gliomas through PI3K\/AKT\/mTOR signaling pathway. J Transl Med 19(1):99","journal-title":"J Transl Med"},{"key":"5900_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.biopha.2016.09.051","volume":"84","author":"Y Wu","year":"2016","unstructured":"Wu Y et al (2016) FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K\/AKT\/mTOR signal pathways. Biomed Pharmacother 84:462\u2013469","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5900_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2015.07.007","volume":"367","author":"Z Yu","year":"2015","unstructured":"Yu Z (2015) NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Cancer Lett 367(1):58\u201368","journal-title":"Cancer Lett"},{"issue":"8","key":"5900_CR40","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1111\/cas.15387","volume":"113","author":"J Zhou","year":"2022","unstructured":"Zhou J et al (2022) LncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K\/AKT pathway in glioma. Cancer Sci 113(8):2681\u20132692","journal-title":"Cancer Sci"},{"issue":"5","key":"5900_CR41","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/neup.12824","volume":"42","author":"L Guo","year":"2022","unstructured":"Guo L, Wu Z (2022) FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K\/AKT\/mTOR signaling pathway. Neuropathology 42(5):430\u2013446","journal-title":"Neuropathology"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05900-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T03:52:46Z","timestamp":1764129166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05900-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5900"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05900-9","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical samples were approved by the Research Ethics Committee of Xiangya Hospital, Central South University, according to the ethical and legal standards of the Declaration of Helsinki. Animal experiments were conducted according to the protocols approved by the Animal Ethics Committee of Medical Research of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors reviewed the results and contributed to the final manuscript. All authors approved this manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"423"}}